Most pediatric patients with migraine have normal imaging, supporting that routine scans rarely aid diagnosis or alter ...

With appropriate care and help from healthcare providers, headache sufferers can learn to manage symptoms and have more symptom-free days.

BRIDGEWATER, N.J. and NETANYA, Israel, June 19, 2025 (GLOBE NEWSWIRE) -- Theranica, a pioneer in drug-free neuromodulation treatments for idiopathic pain conditions, today announced the ...

The migraine aura manifests with more focal neurological symptoms, commonly described as various visual-field changes. These symptoms usually precede the headache by 5–20 min and lasts up to 1 h.

Check out our AURA stock chart to see a history of performance, ... Aura Biosciences Inc. Aura Biosciences Inc AURA. Stock XNAS Rating as of Jun 20, 2025. Download PDF. Summary; Chart; News; ...

AbbVie’s Aquipta has become the first oral therapy for chronic and episodic migraine prevention to be recommended by NICE for NHS use. Skip to main content Monday 23 June 2025 . BlueSky ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

Aura and the IdentityForce®+Credit plan offer comparable protection against identity theft and financial fraud, though IdentityForce's plans provide $2 million in identity theft insurance, twice ...

Front offices know it’s never too early to start preparing for the following year. To help everyone else prepare as well, here are the current rosters for the 2025-26 season, including every … ...